AMT-116 in Patients With Advanced Solid Tumors

NCT05725291 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: AMT-116

Sponsor

Multitude Therapeutics Inc.